Abstract:1031 Objectives: Replacement of the carbon hydrogen bond (C-H) with a carbon-deuterium (C-D) bond often increases in vivo metabolic stability through a reduction in drug metabolism. FDA has recently approved a new deuterated drug, deuterated tetrabenazine (SD-809, Austedo) for treatment of Huntington’s disease. Amyvid (florbetapir, [18F]AV-45) is currently a commercially available PET imaging agent targeting Aβ plaques in the brain for assisting the diagnosis of Alzheimer’s disease. A deuterated analog, [18F]D3FSP ([18F]D3AV-45), was prepared and tested for mapping Aβ plaques in the brain. Methods: [18F]D3FSP, a potential PET imaging agent targeting amyloid plaques in the brain, was prepared using a reaction sequence similar to that of [18F]AV-45. [18F]D3FSP was tested by in vitro binding, autoradiography and in vivo biodistribution studies in normal mice. Results: Binding studies, using either [18F]D3FSP or [18F]AV-45 as the hot ligand, showed that hydrogen to deuterium substitution (AV-45 vs D3FSP) showed the same excellent binding affinity to Aβ aggregate binding sites (Ki = 3 to 4 nM). Within statistical errors the biodistribution of [18F]-AV-45 and [18F]D3FSP in normal mice showed very similar results. [18F]D3FSP and [18F]AV-45 showed comparable initial brain penetration at 2 min after an iv injection with rapid washout in the normal mice brain as shown at later time points (60 and 120 min). Autoradiography of AD brain sections using these two ligands showed very similar binding pattern confirming the high binding affinity to Aβ aggregates. Conclusion: The preliminary results suggest that [18F]D3FSP is a potential PET imaging agent for mapping Aβ plaques in the brain.

18F-Labeled Benzyldiamine Derivatives As Novel Flexible Probes for Positron Emission Tomography of Cerebral Β-Amyloid Plaques.

Novel 18F-Labeled Benzoxazole Derivatives As Potential Positron Emission Tomography Probes for Imaging of Cerebral Β-Amyloid Plaques in Alzheimer’s Disease

Novel ¹⁸F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.

Novel 18F-Labeled Benzofuran Derivatives with Improved Properties for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques in Alzheimer’s Brains

Synthesis and Evaluation of Novel ¹⁸F Labeled 2-Pyridinylbenzoxazole and 2-Pyridinylbenzothiazole Derivatives As Ligands for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques.

Synthesis and Biological Evaluation of 18F-Labled 2-Phenylindole Derivatives As PET Imaging Probes for Β-Amyloid Plaques

Preliminary Characterization and In Vivo Studies of Structurally Identical 18 F- and 125 I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques

Preliminary Characterization and in Vivo Studies of Structurally Identical 18F- and 125I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of Β-Amyloid Plaques

18F-Labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques

Radioiodinated Benzimidazole Derivatives As Single Photon Emission Computed Tomography Probes for Imaging of Β-Amyloid Plaques in Alzheimer's Disease

Radiolabeled pyridinyl analogues of dibenzylideneacetone as beta-amyloid imaging probes

Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of β -amyloid plaques by positron emission tomography

Synthesis and Monkey-PET Study of (R)- and (S)-18F-labeled 2-Arylbenzoheterocyclic Derivatives As Amyloid Probes with Distinctive in Vivo Kinetics.

18F-Labeled 2-Phenylbenzoheterocycles with Chiral Dihydroxyl Side Chains As Β-Amyloid Imaging Probes.

Optically Pure Diphenoxy Derivatives As More Flexible Probes for Β-Amyloid Plaques

99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques.

Development of Dual Functional SPECT/fluorescent Probes for Imaging Cerebral Β-Amyloid Plaques

[F-18]D3FSP ([F-18]D3AV-45) as a PET imaging agent for Abeta plaques in the brain

A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging Β-Amyloid Plaques in the Brain.

Fluorine-18-Labeled Diaryl-azines As Improved Β-Amyloid Imaging Tracers: from Bench to First-in-Human Studies

18F-Radiolabeled Resveratrol Derivatives: Synthesis, Radiolabeling, and Preliminary Evaluation as β-Amyloid Plaque PET Agents